Effects of Ionotropic Glutamate Receptor Blockers on Pentylenetetrazole-Induced Seizures in Krushinskii–Molodkina Rats
- 36 Downloads
Krushinskii–Molodkina (KM) rats have a genetic predisposition to increased audiogenic convulsive readiness and respond to sound signals with clonic-tonic convulsive seizures reminiscent of epileptic attacks in humans. The aims of the present work were to compare the neurological manifestations of the convulsant pentylenetetrazol (corazol) in Wistar and KM rats, i.e., to identify the contribution of genetically caused audiogenic convulsive readiness, and to assess the abilities of the NMDA receptor blockers memantine and 1-phenylcyclohexylamine (IEM-1921) to prevent the actions of pentylenetetrazol in KM rats. Convulsive reactions to administration of pentylenetetrazol were significantly stronger in KM rats than in Wistar rats, and deaths in KM rats were 2.1 times more frequent. Both blockers demonstrated the ability to reduce convulsive reactions to administration of pentylenetetrazol; the prophylactic action of IEM-1921 was more marked. IEM-1921 decreased the mean intensity of convulsive seizures by 2 points on a 5-point scale, while the total duration of generalized seizures decreased 41-fold. IEM-1921 completely prevented deaths among the animals, while memantine produce no more than a tendency to a decrease in lethality (68% in controls, 50% after administration of memantine). The results obtained here provide evidence that NMDA glutamate receptors play an important role in the molecular mechanisms of convulsive syndromes of different etiologies.
Keywordsmemantine IEM-1921 (1-phenylcyclohexylamine) convulsion models NMDA blockers epilepsy
Unable to display preview. Download preview PDF.
- 1.S. I. Vataev, E. P. Zhabko, N. Ya. Lukomskaya, et al., “Effects of memantine on convulsive reactions and the organization of sleep in Krushinskii–Molodkina rats with inherited predisposition to audiogenic convulsions,” Ros. Fiziol. Zh., 95, No. 8, 802–812 (2009).Google Scholar
- 2.N. Ya. Lukomskaya, S. I. Vataev, E. P. Zhabko, and L. G. Magazanik, “Effects of ionotropic glutamate receptor channel blockers on audiogenic convulsive reactions in Krushinskii–Molodkina rats,” Ros. Fiziol. Zh., 98, No. 4, 449–460 (2012).Google Scholar
- 3.N. Ya. Lukomskaya, V. V. Lavrent’eva, L. A. Starshinova, et al., “Involvement of glutamate receptors in the occurrence of arecoline tremor in mice,” Ros. Fiziol. Zh., 93, No. 3, 275–282 (2007).Google Scholar
- 4.N. Ya. Lukomskaya, V. V. Lavrent’eva, L. A. Starshinova, et al., “Effects of ionotropic glutamate receptor channel blockers on the development of pentylenetetrazol kindling in mice,” Ros. Fiziol. Zh., 91, No. 11, 1241–1251 (2005).Google Scholar
- 5.N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, et al., “Comparison of the anticonvulsive activity of organic mono- and dications and their abilities of the inhibit NMDA and AMPA glutamate receptors,” Ros. Fiziol. Zh., 88, No. 9, 1161–1171 (2002).Google Scholar
- 6.N. Ya. Lukomskaya, N. I. Rukoyatkina, L. V. Gorbunova, et al., “Studies of the role of NMDA and AMPA glutamate receptors in the mechanisms of corazol convulsions in mice,” Ros. Fiziol. Zh., 89, No. 3, 292–301 (2003).Google Scholar
- 7.N. I. Rukoyatkina, L. V. Gorbunova, V. E. Gmiro, and N. Ya. Lukomskaya, “The ability of new noncompetitive glutamate receptor blockers to weaken motor impairments in animals,” Ros. Fiziol. Zh., 87, No. 9, 1260–1267 (2001).Google Scholar
- 8.A. F. Semiokhina, I. B. Fedotova, and I. I. Poletaeva, “ Krushinskii–Molodkina rats: studies of audiogenic epilepsy, vascular pathology, and behavior,” Zh. Vyssh. Nerv. Deyat., 56, No. 3, 298–316 (2006).Google Scholar
- 34.Y. Takahashi, M. Sadamatsu, H. Kanai, et al., “Changes in immunoreactive neuropeptide Y, somatostatin and corticotropin-releasing factor (CRF) in the brain of a novel epileptic mutant rat, Ihara’s genetically epileptic rat (IGER),” Brain Res., 776, No. 1–2, 255–260 (1997).PubMedCrossRefGoogle Scholar